David M. Mott - 21 Jan 2025 Form 4 Insider Report for ARDELYX, INC. (ARDX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Jan 2025, 17:25:52 UTC
Prior SEC filing
27 Dec 2024
Next SEC filing
26 Feb 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Elizabeth Grammer, Attorney-in-Fact for David Mott

Key filing fact

David M. Mott filed Form 4 for ARDELYX, INC. (ARDX) on 22 Jan 2025.

Key facts

  • This page summarizes David M. Mott's Form 4 filing for ARDELYX, INC. (ARDX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 22 Jan 2025, 17:25.

Change

  • Previous filing in this sequence was filed on 27 Dec 2024.
  • Current net transaction value: +$992,672.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ARDX transaction

Common Stock

Purchase

Transaction value
$992,672
Shares
+199,000
Change %
+11%
Price
$4.99
Shares after
1,937,765
Date
21 Jan 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Reporting Person holds 87,566 shares for the benefit of entities associated with New Enterprise Associates and disclaims beneficial ownership of such shares, except to the extent of his actual pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .